Conclusion:
Cardiac tamponade is a rare complication of COVID-19 infection.
Physicians must be cognizant of this possibility in patients with
cardiovascular decompensation. Ultrasonography can aid in rapid
diagnosis, and drainage of pericardial fluid and can result in clinical
improvement. Short-term prognosis appears to depend upon ventricular
function. Role of corticosteroids, NSAIDs, and immune modulators remains
unclear in this subgroup of COVID-19 patients, but may have a role in
preventing the development of ventricular failure caused by the marked
inflammatory response and stress cardiomyopathy.